280 related articles for article (PubMed ID: 27408876)
1. FDG-Avid Portal Vein Tumor Thrombosis from Hepatocellular Carcinoma in Contrast-Enhanced FDG PET/CT.
Nguyen XC; Nguyen DS; Ngo VT; Maurea S
Asia Ocean J Nucl Med Biol; 2015; 3(1):10-7. PubMed ID: 27408876
[TBL] [Abstract][Full Text] [Related]
2. Value of
Wu B; Zhang Y; Tan H; Shi H
Abdom Radiol (NY); 2019 Jul; 44(7):2430-2435. PubMed ID: 30944961
[TBL] [Abstract][Full Text] [Related]
3. Role of ¹⁸F-FDG PET CT as an independent prognostic indicator in patients with hepatocellular carcinoma.
Pant V; Sen IB; Soin AS
Nucl Med Commun; 2013 Aug; 34(8):749-57. PubMed ID: 23689586
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of FDG Uptake of Portal Vein Tumor Thrombosis in Patients With Locally Advanced Hepatocellular Carcinoma.
Lee JW; Hwang SH; Kim DY; Han KH; Yun M
Clin Nucl Med; 2017 Jan; 42(1):e35-e40. PubMed ID: 27775940
[TBL] [Abstract][Full Text] [Related]
5. Highly metabolic thrombus of the portal vein: 18F fluorodeoxyglucose positron emission tomography/computer tomography demonstration and clinical significance in hepatocellular carcinoma.
Sun L; Guan YS; Pan WM; Chen GB; Luo ZM; Wei JH; Wu H
World J Gastroenterol; 2008 Feb; 14(8):1212-7. PubMed ID: 18300346
[TBL] [Abstract][Full Text] [Related]
6. Extrahepatic metastases of hepatocellular carcinoma on
Sarma M; Padma S; Pavithran P; Somasundaram VH; Sundaram PS
J Egypt Natl Canc Inst; 2021 Nov; 33(1):36. PubMed ID: 34825288
[TBL] [Abstract][Full Text] [Related]
7. Relationship between SUVmax on 18F-FDG PET and PD-L1 expression in hepatocellular carcinoma.
Zhou X; Hu Y; Sun H; Chen R; Huang G; Liu J
Eur J Nucl Med Mol Imaging; 2023 Aug; 50(10):3107-3115. PubMed ID: 37147479
[TBL] [Abstract][Full Text] [Related]
8. Isolated Malignant Portal Vein Thrombus in Colon Carcinoma: A Rare Finding on
Jain TK; Yadav A; Malhotra H; Khunteta N; Singh G
J Nucl Med Technol; 2021 Jun; 49(2):190-192. PubMed ID: 33219156
[TBL] [Abstract][Full Text] [Related]
9. Decrease in total lesion glycolysis and survival after yttrium-90-radioembolization in poorly differentiated hepatocellular carcinoma with portal vein tumour thrombosis.
Filippi L; Di Costanzo GG; D'Agostini A; Tortora R; Pelle G; Cianni R; Schillaci O; Bagni O
Nucl Med Commun; 2018 Sep; 39(9):845-852. PubMed ID: 29901488
[TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography/computed tomography with (18)F-fluorodeoxyglucose identifies tumor growth or thrombosis in the portal vein with hepatocellular carcinoma.
Sun L; Wu H; Pan WM; Guan YS
World J Gastroenterol; 2007 Sep; 13(33):4529-32. PubMed ID: 17724816
[TBL] [Abstract][Full Text] [Related]
11. Contrast-enhanced ultrasound in differentiating malignant from benign portal vein thrombosis in hepatocellular carcinoma.
Tarantino L; Ambrosino P; Di Minno MN
World J Gastroenterol; 2015 Aug; 21(32):9457-60. PubMed ID: 26327753
[TBL] [Abstract][Full Text] [Related]
12. Metabolic restaging of hepatocellular carcinoma using whole-body F-FDG PET/CT.
Sun L; Guan YS; Pan WM; Luo ZM; Wei JH; Zhao L; Wu H
World J Hepatol; 2009 Oct; 1(1):90-7. PubMed ID: 21160970
[TBL] [Abstract][Full Text] [Related]
13. Portal venous tumor growth-type of hepatocellular carcinoma without liver parenchyma tumor nodules: a case report.
Saito M; Seo Y; Yano Y; Uehara K; Hara S; Momose K; Hirano H; Yokozaki H; Yoshida M; Azuma T
Ann Hepatol; 2013; 12(6):969-73. PubMed ID: 24114829
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of contrast-enhanced FDG PET/CT in patients awaiting liver transplantation with rising alpha-fetoprotein after bridge therapy of hepatocellular carcinoma.
Refaat R; Basha MAA; Hassan MS; Hussein RS; El Sammak AA; El Sammak DAEA; Radwan MHS; Awad NM; Saad El-Din SA; Elkholy E; Ibrahim DRD; Saleh SA; Montasser IF; Said H
Eur Radiol; 2018 Dec; 28(12):5356-5367. PubMed ID: 29948070
[TBL] [Abstract][Full Text] [Related]
15. Tumor thrombus: ancillary findings on FDG PET/CT in an oncologic population.
Ravina M; Hess S; Chauhan MS; Jacob MJ; Alavi A
Clin Nucl Med; 2014 Sep; 39(9):767-71. PubMed ID: 24999677
[TBL] [Abstract][Full Text] [Related]
16. A (18)F-FDG PET/CT Screening Study of a Hepatocellular Carcinoma Patient with Diffuse (18)F-FDG Uptake into the Portal Vein and its Intrahepatic Branches.
Koroglu R; Koksal I; Gezer F; Kahraman A; Kekilli E
World J Nucl Med; 2016; 15(1):68-70. PubMed ID: 26912985
[TBL] [Abstract][Full Text] [Related]
17.
Kesler M; Levine C; Hershkovitz D; Mishani E; Menachem Y; Lerman H; Zohar Y; Shibolet O; Even-Sapir E
J Nucl Med; 2019 Feb; 60(2):185-191. PubMed ID: 30002112
[No Abstract] [Full Text] [Related]
18. Malignant Portal Vein Thrombosis with No Obvious Liver Parenchymal Mass on Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Chandra P; Sethi A; Chinnappan S
Indian J Nucl Med; 2023; 38(4):404-406. PubMed ID: 38390545
[TBL] [Abstract][Full Text] [Related]
19. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
20. (68)Ga-DOTA-peptide: A novel molecular biomarker for nasopharyngeal carcinoma.
Khor LK; Loi HY; Sinha AK; Tong KT; Goh BC; Loh KS; Lu SJ
Head Neck; 2016 Apr; 38(4):E76-80. PubMed ID: 26275126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
